Rapid molecular detection of Macrolide resistance in the Mycobacterium avium complex: Are we there yet?

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2425-2426

  Christianson, Sara ^a   Grierson, William ^a   Wolfe, Joyce ^a   Sharma, Meenu K ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE; RNA 23S; ANTIINFECTIVE AGENT; BACTERIAL DNA; RIBOSOME DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DNA SEQUENCE; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; CHEMISTRY; DRUG EFFECTS; EVALUATION STUDY; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MOLECULAR DIAGNOSIS; MYCOBACTERIUM AVIUM COMPLEX; PROCEDURES; SENSITIVITY AND SPECIFICITY;

MYCOBACTERIUM AVIUM COMPLEX;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM AVIUM COMPLEX; RNA, RIBOSOMAL, 23S; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 84879430422     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00555-13     Document Type: Article

References (8)

1. American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical section of the American Lung Association. Am. J. Respir. Crit. Care Med. 156:S1-S25.
2. Clinical and Laboratory Standards Institute. 2011. Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes: Approved standard, 2nd ed. Document M24-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ, Jr. 2006. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am. J. Respir. Crit. Care Med. 174:928-934.
4. Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K. 2011. Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates. J. Antimicrob. Chemother. 66:722-729.
5. Jamal MA, Maeda S, Nakata N, Kai M, Fukuchi K, Kashiwabara Y. 2000. Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. Tuber. Lung Dis. 80:1-4.
6. Meier A, Heifets L, Wallace RJ, Jr, Zhang Y, Brown BA, Sander P, Bottger EC. 1996. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J. Infect. Dis. 174:354-360.
7. Meier A, Kirschner P, Springer B, Steingrube VA, Brown BA, Wallace RJ, Jr, Bottger EC. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
8. Nash KA, Inderlied CB. 1995. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob. Agents Chemother. 39:2625-2630.